Abstract
New analogues of nifedipine, in which the 2‐nitrophenyl group at position 4 is replaced by a 1‐methyl‐5‐nitro‐2‐imidazolyl substituent, were synthesized. The symmetrical dialkyl 1, 4‐dihydro‐2, 6‐dimethyl‐4‐(1‐methyl‐5‐nitro‐2‐imidazolyl)‐3, 5‐pyridinedicarboxylates were prepared by a classical Hantzsch condensation. The asymmetrical analogues were synthesized using a procedure reported by Iwanami that involved the condensation of alkylacetoacetate with methyl‐, ethyl‐ or isopropyl3‐aminocrotonate and 1‐methyl‐5‐nitroimidazole‐2‐carboxaldehyde. Calcium channel antagonist activities were determined in vitro using a guinea pig ileum longitudinal smooth muscle (GPILSM)assay. Many compounds exhibited superior, or equipotent, calcium antagonist activity (IC50 = 10—10 to 10—13 M range) relative to the reference drug nifedipine (IC50 = 1.09 ± 0.12 × 10—11 M). Antinociceptive effects of some compounds were evaluated by the mouse tail‐flick assay in vivo. Results demonstrate that some of the compounds were active as an antinociceptive.

This publication has 19 references indexed in Scilit: